Molecular Networks

Molecular Networks is a specialized chemoinformatics company that provides advanced software solutions for drug discovery, chemical safety, and computational toxicology. Founded in 1997 as a spin-off from the University of Erlangen-Nuremberg, the company has established itself as a leader in 3D molecular structure generation and toxicity prediction. Its flagship products, CORINA and ChemTunes·ToxGPS, are utilized by major pharmaceutical, biotechnology, and cosmetic companies, as well as regulatory bodies like the US FDA. The company's technology supports in silico profiling, metabolic fate prediction, and risk assessment, helping to reduce the need for animal testing. In January 2025, Molecular Networks was acquired by Lhasa Limited to further integrate their expertise in chemical safety science.